Omada Health, Inc. OMDA
NasdaqSmall CapHealthcare
13F Pro quality score
Rank #900 of 2,925TOP 50%
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reading the latest SEC filing…
13F Pro quality score
Rank #900 of 2,925TOP 50%
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from Omada Health, Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $260.2M | $-12.8M | -4.6% |
| FY 2024 | 10-K | $169.8M | $-47.1M | -25.7% |
| FY 2023 | 10-K | $122.8M | $-67.5M | -53.8% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
Omada Health, Inc. (OMDA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OMDA at 59.9/100 on a composite quality score built from its SEC filings, placing it at rank #900 of 2,925 stocks — the top half of the AI-ranked universe. OMDA scores in the top quartile across earnings quality (97.6), revenue growth (86.6), institutional flow (80.5). Areas of concern include revenue scale (30.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 24.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Omada Health, Inc. reports quarterly revenue of $87.8M, net income of $5.3M, an operating margin of 4.0%. OMDA trades on the Nasdaq exchange and files with the SEC under CIK 1611115. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OMDA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Omada Health, Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1611115 →